Journals / Balkan Medical Journal / 2022 / Cilt: 39 - Sayı: 2

Premature Myocardial Infarction: A Rising Threat

Pages
83–95
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review is aimed to discuss and guide the risk factor assessment for the development of myocardial infarction in young individuals based on current evidence and our >20-year of experience in Young Myocardial Infarction Clinic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Myocardial infarction mostly presents with atypical signs and symptoms and has different risk factors in young individuals compared to older individuals.
📊
Key Findings & Data:Scarcity of studies and lack of guidelines for assessment and management of young MI patients, make it more challenging for these individuals to get accurate medical care, even though MI in this age group is on the rise.
💡
Conclusion & Impact:This review is aimed to discuss and guide the risk factor assessment for the development of myocardial infarction in young individuals based on current evidence and our >20-year of experience in Young Myocardial Infarction Clinic.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Myocardial infarction mostly presents with atypical signs and symptoms and has different risk factors in young individuals compared to older individuals. These risk factors are often preventable, therefore recognizing them and taking precautions can save these patients from suffering myocardial infarction. Scarcity of studies and lack of guidelines for assessment and management of young MI patients, make it more challenging for these individuals to get accurate medical care, even though MI in this age group is on the rise. Traditional risk factors, such as smoking, hyperlipidemia, hypertension, male sex, obesity, and family history of premature cardiovascular disease, contribute to the risk of myocardial infarction at a young age, but additional non-traditional risk factors, such as substance abuse, thrombophilia, coronary anomalies, immune disease, allergic reactions, and psychological stressors, uniquely contribute to the risk profile of young individuals. This review is aimed to discuss and guide the risk factor assessment for the development of myocardial infarction in young individuals based on current evidence and our >20-year of experience in Young Myocardial Infarction Clinic.

🔖

Cite This Article

KAYIKÇIOĞLU, M., ÖZKAN, H. S., YAĞMUR, B. (2022). Premature Myocardial Infarction: A Rising Threat. Balkan Medical Journal, Cilt: 39 - Sayı: 2, 83–95. https://ajindex.com/articles/648939

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Yang J, Biery DW, Singh A, et al. Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry. Am J Med. 2020
  2. [CrossRef] 2. Cengel A, Tanindi A. Myocardial infarction in the young. J Postgrad Med. 2009
  3. [CrossRef] 3. Case BC, Abramowitz J, Shea C, et al. Evolution of Management and Outcomes of Patients with Myocardial Injury During the COVID-19 Pandemic. Am J Cardiol. 2021
  4. [CrossRef] 4. Ambroziak M, Niewczas-Wieprzowska K, Maicka A, Budaj A. Younger age of patients with myocardial infarction is associated with a higher number of relatives with a history of premature atherosclerosis. BMC Cardiovasc Disord. 2020
  5. [CrossRef] 5. Yamac AH, Uysal O, Ismailoglu Z, et al. Premature Myocardial Infarction: Genetic Variations in SIRT1 Affect Disease Susceptibility. Cardiol Res Pract. 2019
  6. 8921806. [CrossRef] 6. Gulati R, Behfar A, Narula J, et al. Acute Myocardial Infarction in Young Individuals. Mayo Clin Proc. 2020
  7. [CrossRef] 7. Rallidis LS, Lekakis J, Panagiotakos D, et al. Long-term prognostic factors of young patients. Eur J Cardiovasc Prev Rehabil. 2008
  8. [CrossRef] 8. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med. 1984
  9. [CrossRef] 9. Tokgozoglu L, Kayikcioglu M, Ekinci B. The landscape of preventive cardiology in Turkey: Challenges and successes. Am J Prev Cardiol. 2021
  10. 100184. [CrossRef] 10. Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III: A survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil. 2009
  11. [CrossRef] 11. Tokgözoğlu L, Kayıkçıoğlu M, Altay S, et al. [EUROASPIRE-IV: European Society of Cardiology study of lifestyle, risk factors, and treatment approaches in patients with coronary artery disease: Data from Turkey]. Turk Kardiyol Dern Ars. 2017
  12. [CrossRef] 12. Erol MK, Kayıkçıoğlu M, Kılıçkap M, et al. Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: A nationwide study. Anatol J Cardiol. 2020
  13. [CrossRef] 13. Dugani SB, Murad W, Damilig K, et al. Premature Myocardial Infarction in the Middle East and North Africa: Rationale for the Gulf PREVENT Study. Angiology. 2020
  14. [CrossRef] 14. Setia N, Verma IC, Khan B, Arora A. Pr